UPDATE: Goldman Sachs Resumes Coverage on Health Care REIT on High-Quality Portfolio, Lower Earnings Growth

In a report published Tuesday, Goldman Sachs analyst Andrew Rosivach resumed coverage on Health Care REIT (NYSE: HCN ) with a Neutral rating and $61.00 price target. In the report, Goldman Sachs noted, “We resume coverage of Health Care REIT, Inc. (HCN) with a Neutral rating and a 12-month price